文章核心观点 - 根据文件,Orthofix Medical Inc.(NASDAQ: OFIX)的管理团队涉及"重复不当和冒犯性行为,违反了多项行为准则要求",这与公司宣称的价值观和文化不符 [1][2] - 这一披露尤其令人不安,因为此前公司曾保证其管理团队由致力于按照最高道德和法律标准开展业务的个人组成,并且这些个人相信并培养了一种以诚信、协作、创新、多样性和企业责任为重点的强大绩效文化 [2] 根据相关目录分别进行总结 公司概况 - Orthofix Medical Inc.是一家上市公司,股票代码为NASDAQ: OFIX [1] 涉诉事项 - 根据起诉书,公司管理团队存在"重复不当和冒犯性行为,违反了多项行为准则要求" [1][2] - 这与公司此前宣称的管理团队致力于按照最高道德和法律标准开展业务,并相信和培养以诚信、协作、创新、多样性和企业责任为重点的强大绩效文化的说法不符 [2] 诉讼进展 - 公司股东被鼓励就可能成为集体诉讼的首席原告一事与律师事务所联系 [1] - 集体诉讼的时间范围为2022年10月11日至2023年9月12日 [2] - 首席原告申请截止日期为2024年10月21日,参与无需任何费用或义务 [3]

文章核心观点 - 根据诉讼,在整个Class Period期间,被告未能向投资者披露Orthofix管理团队参与了"重复的不当和令人不快的行为,违反了多项行为准则要求",且"与公司的价值观和文化不一致" [2][3] - 2023年9月12日,Orthofix披露其独立董事一致决定终止Keith Valentine、John Bostjancic和Patrick Keran在首席执行官、首席财务官和首席法务官等职位上的聘用,并要求Valentine先生辞去董事会职务 [3] - 公司表示,这一决定是根据独立外部法律顾问的调查结果做出的,调查由公司独立董事指导和监督,董事会认定这些高管的行为"违反了多项行为准则要求,与公司的价值观和文化不一致" [3] - 这一消息公布后,Orthofix股价下跌30.2%,每股从18.63美元下跌至13.01美元 [3] 公司概况 - Orthofix总部位于德克萨斯州的Lewisville,是一家全球性的脊柱和骨科公司,为全球医疗专业人士提供生物材料、脊柱硬件、骨生长疗法和专业骨科解决方案等 [2] 诉讼信息 - 该证券欺诈集体诉讼针对2022年10月11日至2023年9月12日期间(Class Period)购买或获得Orthofix证券的投资者 [1] - 投资者如果在Class Period内购买或获得Orthofix证券,最迟可在2024年10月21日前申请担任集体代表原告 [1] - 投资者可以联系Berger Montague律所的Andrew Abramowitz或Peter Hamner获取更多信息 [1][5][6] - Berger Montague律所自1970年成立以来一直是证券集体诉讼的先驱,在全美各地法院担任首席代理人 [5]

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=107858&from=4 CLASS PERIOD: October 11, 2022 t ...

SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The notice originally published on September 10, 2024, incorrectly stated that the filing deadline for lead plaintiff motions is November 8, 2024. The correct filing deadline for lead plaintiff motions is November 12, 2024. This correction is reflected in the corrected notice below. Girard Sharp LLP and The Hall Firm, Ltd., both national law firms specializing in complex class actions and shareholder rights, announce they have filed a class action lawsuit for ...

NEW YORK, Oct. 10, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=107498&from=4 CLASS PERIOD: October 11, 2022 t ...

SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of former SeaSpine Holdings Corporation shareholders that purchased or otherwise acquired newly issued Orthofix Medical Inc. (NASDAQ: OFIX) stock in exchange for SeaSpine shares pursuant to the January 5, 2023 stock-for-stock transaction by which Orthofix merged with and acquires SeaSpine. Orthofix is a global spine and orthopedics company that offers biologics, spinal hardware, bone ...

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=107026&from=3 CLASS PERIOD: October 11, 20 ...

NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased Orthofix common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a ...

NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=106353&from=3 CLASS PERIOD: October 11, 20 ...

NEW YORK, Sept. 30, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/orthofix-loss-submission-form/?id=105564&from=4 CLASS PERIOD: October 11, 2022 ...